Inflectra and Foot deformity - a phase IV clinical study of FDA data

Summary:

Foot deformity is reported as a side effect among people who take Inflectra (infliximab-dyyb), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Methotrexate, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Foot deformity when taking Inflectra. It is created by eHealthMe based on reports of 52,342 people who have side effects when taking Inflectra from the FDA, and is updated regularly.

What is Inflectra?

Inflectra has active ingredients of infliximab-dyyb. eHealthMe is studying from 52,370 Inflectra users. Check the latest studies of Inflectra.

What is Foot deformity?

Foot deformity (functional disability of foot) is found to be associated with 909 drugs and 707 conditions by eHealthMe. Check the latest studies of Foot deformity.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

52,342 people reported to have side effects when taking Inflectra.
Among them, 75 people (0.14%) have Foot deformity.

Among these 75 people:

How long have people been on Inflectra when they have Foot deformity? *

What is the gender of people who have Foot deformity when taking Inflectra? *

female: 100 %
male: 0.0 %

What is the age of people who have Foot deformity when taking Inflectra? *

What are other drugs people take besides Inflectra? *

Methotrexate: 22 people, 29.33%
Enbrel: 14 people, 18.67%
Arava: 14 people, 18.67%
Folic Acid: 14 people, 18.67%
Prednisone: 13 people, 17.33%
Remicade: 13 people, 17.33%
Gravol: 9 people, 12.00%
Calcium: 9 people, 12.00%
Humira: 8 people, 10.67%
Hydroxychloroquine Sulfate: 7 people, 9.33%

What are other side effects people have besides Foot deformity? *

High Blood Pressure: 42 people, 56.00%
Fatigue (feeling of tiredness): 39 people, 52.00%
Nausea (feeling of having an urge to vomit): 33 people, 44.00%
Pain: 32 people, 42.67%
Malaise (a feeling of general discomfort or uneasiness): 29 people, 38.67%
Blood Pressure Fluctuation: 27 people, 36.00%
Headache (pain in head): 25 people, 33.33%
Nausea And Vomiting: 24 people, 32.00%
Oropharyngeal Pain: 24 people, 32.00%
Dyspnea (difficult or laboured breathing): 24 people, 32.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 42 people, 56.00%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 17 people, 22.67%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 11 people, 14.67%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 6 people, 8.00%
Psoriasis (immune-mediated disease that affects the skin): 6 people, 8.00%
Arrhythmias (irregular heartbeat): 5 people, 6.67%
Osteoporosis (bones weak and more likely to break): 5 people, 6.67%
Pain: 4 people, 5.33%
Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 4 people, 5.33%
Lipids Abnormal: 4 people, 5.33%

* Approximation only. Some reports may have incomplete information.

Do you take Inflectra and have Foot deformity?

- Check whether Foot deformity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Inflectra:

Inflectra (52,370 reports)

Foot deformity treatments and more:

Foot deformity (14,397 reports)

Browse all side effects of Inflectra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Foot deformity:

Foot deformity (909 drugs)

Browse all the conditions that are associated with Foot deformity:

Foot deformity (707 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on infliximab-dyyb (the active ingredients of Inflectra) and Inflectra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.